| HOME >> BIOLOGY >> TECHNOLOGY |
BEDFORD, Mass., Jan. 30 /PRNewswire-FirstCall/ -- Hologic, Inc. (Nasdaq: HOLX) today announced that Patrick Sullivan, Executive Chairman and Glenn Muir, Chief Financial Officer, will be presenting at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference being held February 5-7, 2008 at the Grand Hyatt Hotel in New York, NY.
Interested parties are invited to listen to a live audio webcast of Hologic's investor presentation on Tuesday, February 5, 2008 at 1:40 p.m. Eastern Time on the investor section of the Company's website at http://www.hologic.com/investor. An archive of the presentation will be available for replay following the conference.
About Hologic, Inc.
Hologic, Inc. is a leading developer, manufacturer and supplier of
premium diagnostics, medical imaging systems and surgical products
dedicated to serving the healthcare needs of women. Hologic leads the
industry in digital mammography systems and offers the most advanced
technology for breast imaging and breast biopsy. Hologic's core business
units are focused on breast health, diagnostics, GYN surgical, and skeletal
health. Hologic provides a comprehensive suite of technologies with
products for mammography and breast biopsy, radiation treatment for
early-stage breast cancer, cervical cancer screening, treatment for
menorrhagia, osteoporosis assessment, preterm birth risk assessment, and
mini C-arm for extremity imaging. For more information visit
http://www.hologic.com.
Contact: Glenn P. Muir
Executive Vice President and CFO
Hologic, Inc.
(781) 999-7300
Frances Crecco
Director, Investor Relations
Hologic, Inc.
(781) 999-7377
'/>"/>
| SOURCE Hologic, Inc. Copyright©2008 PR Newswire. All rights reserved |
Related biology technology :
1. Hologic, Inc. to Release First Quarter Fiscal 2008 Operating Results Thursday, January 31st Before Market Opens
2. Tengion to Present at Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference
3. 3SBio Inc. to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
4. BioMarin to Present at the Merrill Lynch 2008 Global Healthcare Conference
5. Sagent Pharmaceuticals, Inc. to Present at Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
6. Thermo Fisher Scientific to Present at the 2008 Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference
7. Ardea Biosciences to Present Preclinical Data on Three HIV Non-Nucleoside Reverse Transcriptase Inhibitors During 15th Annual Conference on Retroviruses and Opportunistic Infections
8. Allos Therapeutics to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
9. Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference to Webcast Alexzas Corporate Presentation
10. Kendle to Present at the Wachovia 2008 Healthcare Conference
11. Phytomedics Inc. to Present at Wachovia 2008 Healthcare Conference
| Copyright © 2003-2012 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |